Search       
The Number One Website for Pune City. Sunday, November 19, 2017  |  12:46:51 PM
Bangalore | Chennai | Mumbai | New Delhi | Goa | Hyderabad | Jaipur | Cochin | Coimbatore | Kolkata| Ahmedabad
Choose Your Language
HomeSightseeing Hotels Eatouts & Pubs IT & Bio-Tech Real Estate Lifestyle & Fashion Photo Features Panorama 360° Virtual City Learn MarathiArt & Culture Yellow Pages
Biocon Limited

biocon-logo
Established in 1978, Biocon Limited is India's largest biotechnology company by revenue. The Group, promoted by Ms. Kiran Mazumdar-Shaw, is a fully-integrated, innovation-driven healthcare enterprise with strategic focus on biopharmaceuticals and research services. Biocon's value chain traverses the entire length of discovery, development and commercialization of novel therapeutics. With successful initiatives in clinical development, bio-processing and global marketing, Biocon delivers products and solutions to partners and customers in approximately 75 countries across the globe. Many of these products have USFDA and EMEA acceptance.

Biocon's robust product offering includes the world's first Pichia-based recombinant human insulin, INSUGEN and India's first indigenously produced monoclonal antibody BIOMAb-EGFR(TM).Biocon is the first Indian company to manufacture and export enzymes to USA and Europe.Biocon becomes the first Indian company to be approved by US FDA for the manufacture of lovastatin, a cholesterol-lowering molecule.Biocon's proprietary bioreactor, PlaFractor is granted a US 2001 and world-wide patent.
Biocon Biocon is among Top 20 Indian companies in Forbes 'Best Under A Billion' list. Kiran Mazumdar-Shaw has received several awards on behalf of Biocon and in her personal capacity as India's leading business entrepreneurs, Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector, IDMA "Best Patent of the year" award, Karnataka Rajyotsava Award for pioneering biotechnology in India to name a few.

Leveraging India's globally competitive cost base and exceptional scientific people resource, Biocon is advancing their in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical and biotechnology majors through their subsidiary companies, Syngene and Clinigene.

With the successful commercial launch of their first anti-cancer drug and several promising discovery partnerships in the clinic, Biocon remain committed to scaling new heights in frontier science and achieving new milestones in affordable medicine.

Corporate Headquarters
20th KM, Hosur Road,
Electronics City, Bangalore, India - 560 100
Phone: 91 80 2808 2808 / 91 80 4014 4014
Fax: 91 80 2852 3423
Email:contact.us@biocon.com
URL:www.biocon.com